We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Vanguard Small-Cap Growth ETF
VBK
$23.2B
| $342K | ﹤0.01% |
1,592
| – | – |
|
552
iShares MSCI China ETF
MCHI
$6.04B
| $333K | ﹤0.01% |
4,500
-277
| -6% | -$20.3K |
|
553
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $333K | ﹤0.01% |
5,714
+1,700
| +42% | +$96.1K |
|
554
Landmark Bancorp
LARK
$192M
| $332K | ﹤0.01% |
20,868
| – | – |
|
555
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
| $331K | ﹤0.01% |
9,600
| – | – |
|
556
iShares MSCI Japan Small-Cap ETF
SCJ
$251M
| $330K | ﹤0.01% |
4,500
| – | – |
|
|
RAVN
557
DELISTED
Raven Industries Inc
RAVN
| $330K | ﹤0.01% |
15,350
| – | – |
|
558
Deere & Co
DE
$170B
| $328K | ﹤0.01% |
1,481
-8
| -0.5% | -$1.54K |
|
559
Acadia Realty Trust
AKR
$2.99B
| $323K | ﹤0.01% |
30,771
+4,800
| +18% | +$57.4K |
|
560
Rollins
ROL
$18.6B
| $323K | ﹤0.01% |
8,960
| – | – |
|
561
Atlantic Union Bankshares
AUB
$5.99B
| $320K | ﹤0.01% |
15,000
| – | – |
|
562
H&R Block
HRB
$5.18B
| $319K | ﹤0.01% |
19,621
-11,578
| -37% | -$170K |
|
|
QVCGA
563
DELISTED
QVC Group Inc Series A
QVCGA
| $319K | ﹤0.01% |
891
-39
| -4% | -$18.4K |
|
564
Coca-Cola Europacific Partners
CCEP
$46.5B
| $318K | ﹤0.01% |
8,200
-1,000
| -11% | -$40.9K |
|
565
Entergy
ETR
$54.1B
| $315K | ﹤0.01% |
6,404
+416
| +7% | +$20.6K |
|
566
Pentair
PNR
$10.2B
| $313K | ﹤0.01% |
6,839
+28
| +0.4% | +$1.22K |
|
567
Invesco Golden Dragon China ETF
PGJ
$92.8M
| $311K | ﹤0.01% |
5,908
+3
| +0.1% | +$156 |
|
568
Cadiz
CDZI
$266M
| $310K | ﹤0.01% |
31,250
| – | – |
|
|
HBI
569
DELISTED
Hanesbrands
HBI
| $308K | ﹤0.01% |
19,580
-548
| -3% | -$8.04K |
|
570
Tanger
SKT
$4.82B
| $306K | ﹤0.01% |
50,875
-37,435
| -42% | -$235K |
|
571
Interactive Brokers
IBKR
$40.9B
| $302K | ﹤0.01% |
25,000
| – | – |
|
572
Lumentum
LITE
$59.4B
| $300K | ﹤0.01% |
4,000
+500
| +14% | +$41.4K |
|
573
Carter Bankshares
CARE
$756M
| $299K | ﹤0.01% |
45,032
+20,000
| +80% | +$143K |
|
574
Beyond Meat
BYND
$288M
| $297K | ﹤0.01% |
1,792
| – | – |
|
|
CDK
575
DELISTED
CDK Global, Inc.
CDK
| $296K | ﹤0.01% |
6,802
-166
| -2% | -$7.38K |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.